Case Match Control Analysis of Propel Reveals a Survival Advantage for Patients With Relapsed PTCL Receiving Pralatrexate: A Novel Approach to Benchmark Drugs in Rare Diseases

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Phase 1 Study of Pralatrexate Plus Romidepsin Reveals Marked Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Survival Benefit With Novel Agents in Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (Ptcl): The Columbia University Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Kaposi’s Sarcoma in Patients With Ulcerative Colitis Receiving Immunosuppressive Drugs: Report of a Case

Turkish Journal of Gastroenterology
Gastroenterology
2011English

PUK2 Issues in the Systematic Review of Drugs for Rare Diseases: A Case Study of Eculizumab for aHUS

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

20-Year Survival Data Analysis of PTCL Patients in Peking University Cancer Hospital

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

Frontiers in Pharmacology
Pharmacology
2018English

Novel Therapeutic Approach Mediated by Microglia for Rare Brain Diseases

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Oral Azacytidine (Aza) and Romidepsin (R) Reveals Promising Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Preclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Case-Control Study

Annals of Translational Medicine
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy